Resmed (RMD) Total Non-Current Liabilities (2016 - 2025)
Resmed (RMD) has disclosed Total Non-Current Liabilities for 16 consecutive years, with $934.4 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Total Non-Current Liabilities fell 9.84% year-over-year to $934.4 million, compared with a TTM value of $934.4 million through Dec 2025, down 9.84%, and an annual FY2025 reading of $1.2 billion, up 8.17% over the prior year.
- Total Non-Current Liabilities was $934.4 million for Q4 2025 at Resmed, roughly flat from $931.6 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $2.2 billion in Q4 2022 and bottomed at $930.7 million in Q2 2021.
- Average Total Non-Current Liabilities over 5 years is $1.3 billion, with a median of $1.1 billion recorded in 2021.
- The sharpest move saw Total Non-Current Liabilities tumbled 41.27% in 2021, then skyrocketed 127.85% in 2022.
- Year by year, Total Non-Current Liabilities stood at $967.8 million in 2021, then skyrocketed by 127.85% to $2.2 billion in 2022, then fell by 24.76% to $1.7 billion in 2023, then plummeted by 37.54% to $1.0 billion in 2024, then fell by 9.84% to $934.4 million in 2025.
- Business Quant data shows Total Non-Current Liabilities for RMD at $934.4 million in Q4 2025, $931.6 million in Q3 2025, and $1.2 billion in Q2 2025.